Johnson & Johnson (JNJ) Capital Expenditures (2009 - 2025)
Johnson & Johnson (JNJ) reported Capital Expenditures of $1.36 billion for Q3 2026, up 17.7% from $1.16 billion a year earlier and up 3.1% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Capital Expenditures (2009 - 2025) Analysis & Trends
Over the twelve months ended Sep 27, 2026, Johnson & Johnson's Capital Expenditures came in at $5.57 billion, up 20.9% year-over-year; for FY2025, it was $4.83 billion, up 9.2% from FY2024.
- Capital Expenditures has a four-year compound annual growth rate of 9.6% (FY2021 to FY2025).
- By year, Capital Expenditures came in at $4.42 billion in FY2024 (-2.6%), $4.54 billion in FY2023 (+13.3%), $4.01 billion in FY2022 and $3.35 billion in FY2021.
- Five-year quarterly Capital Expenditures spans a low of $795 million in Q1 2025 and a high of $1.84 billion in Q4 2025.
- Year over year, Capital Expenditures has now increased in each of the last six quarters, with growth averaging 13.7% over the last eight quarters.
- The high point for year-over-year Capital Expenditures in five years was Q1 2026 (growth of 31.9%); the low point was Q2 2024 (a decline of 13.2%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $1.32 billion (Q2 2026), $1.05 billion (Q1 2026) and $1.84 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Yr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.84 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.83 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.21 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.11 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.55 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 563.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.63 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 437.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 28, 2025 | 4.83 Bn |
| Dec 29, 2024 | 4.42 Bn |
| Dec 31, 2023 | 4.54 Bn |
| Dec 31, 2022 | -4.01 Bn |
| Dec 31, 2021 | -3.65 Bn |
| Dec 31, 2020 | -3.35 Bn |
| Dec 29, 2019 | 3.50 Bn |
| Dec 30, 2018 | 3.67 Bn |
| Dec 31, 2017 | 3.28 Bn |
| Dec 31, 2016 | -3.23 Bn |
| Dec 31, 2015 | -3.46 Bn |
| Dec 28, 2014 | 3.71 Bn |
| Dec 29, 2013 | 3.60 Bn |
| Dec 30, 2012 | 2.93 Bn |
| Dec 31, 2011 | -2.89 Bn |
| Dec 31, 2010 | -2.38 Bn |
| Dec 31, 2009 | -2.37 Bn |
API Access
Johnson & Johnson Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures-annual&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures-annual", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures-annual&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();